Phathom Pharmaceuticals Overview

Phathom Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PHAT.

Quarterly EBIT

-$15.48M

↑ 80.37% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$230.87M

↑ 181.63% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin